STOCK TITAN

EQV Ventures director Bryan Summers resigns

EVAC announces a director’s resignation without disagreement and adjusts Board committee memberships accordingly.

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

EQV Ventures Acquisition Corp. II (EVAC) reported the resignation of director Bryan Summers from its Board of Directors, effective September 4, 2026. He also resigned from the Nominating and Corporate Governance Committee and the Compensation Committee. The company states that his resignation was not related to any disagreement regarding operations, policies, or practices. On September 11, 2026, the Board reconstituted its committee memberships to reflect this change. EVAC’s securities, including units, Class A ordinary shares with $0.0001 par value, and redeemable warrants exercisable at $11.50 per share, continue to trade on the New York Stock Exchange.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Director resignation effective date September 4, 2026 Effective date of Bryan Summers’ resignation from the Board
Committee reconstitution date September 11, 2026 Date the Board reconstituted committee memberships after the resignation
Class A ordinary share par value $0.0001 per share Par value of EVAC Class A ordinary shares listed on NYSE
Redeemable warrant exercise price $11.50 per share Exercise price for each whole redeemable warrant into one Class A ordinary share
emerging growth company regulatory
"EVAC is identified as an emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
redeemable warrants financial
"Redeemable warrants, each whole warrant exercisable for one Class A ordinary share"
A redeemable warrant is a tradable right that lets its holder buy a company’s shares at a fixed price before a set date, but the issuer has the contract power to cancel (redeem) the warrant early under agreed terms. For investors this matters because early redemption can force decision-making, change the timing of when new shares might be created, and affect potential gains or dilution—much like a store coupon that the issuer can cancel by paying you off instead of letting you use it.
Nominating and Corporate Governance Committee regulatory
"including the Nominating and Corporate Governance Committee"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
Compensation Committee regulatory
"and the Compensation Committee thereof, effective immediately"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Board reconstituted its committee memberships regulatory
"the Board reconstituted its committee memberships as follows"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Board change did EQV Ventures Acquisition Corp. II (EVAC) disclose?

EVAC disclosed that Bryan Summers resigned from its Board of Directors on September 4, 2026, effective immediately. He also resigned from the Nominating and Corporate Governance Committee and the Compensation Committee, and the Board later reconstituted its committee memberships.

Did Bryan Summers resign from EQV Ventures Acquisition Corp. II (EVAC) due to a disagreement?

No. EVAC states that Bryan Summers’ resignation was not related to a disagreement with the company on any matter relating to its operations, policies, or practices. The Board expressed appreciation for his service and contributions.

When did EQV Ventures Acquisition Corp. II (EVAC) reconstitute its Board committees?

In connection with the director resignation, the Board reconstituted its committee memberships on September 11, 2026. The filing states that the Board’s committee composition was updated following this Committee Reconstitution.

What securities of EVAC are listed on the New York Stock Exchange?

EVAC lists units (each one Class A ordinary share plus one-third of a redeemable warrant), Class A ordinary shares with $0.0001 par value per share, and redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an $11.50 exercise price.

Who signed the 8-K for EQV Ventures Acquisition Corp. II (EVAC)?

The report was signed on behalf of EVAC by Tyson Taylor, who is identified as the company’s President and Chief Financial Officer, dated September 11, 2026.

Is EQV Ventures Acquisition Corp. II (EVAC) identified as an emerging growth company?

Yes. The filing identifies EQV Ventures Acquisition Corp. II as an emerging growth company, a status under U.S. securities laws that can provide certain scaled disclosure and regulatory accommodations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0002042902 0002042902 2026-09-04 2026-09-04 0002042902 EVACU:UnitsEachConsistingOfOneClassOrdinaryShare0.0001ParValuePerShareAndOnethirdOfOneRedeemableWarrantMember 2026-09-04 2026-09-04 0002042902 EVACU:ClassOrdinarySharesParValue0.0001PerShareMember 2026-09-04 2026-09-04 0002042902 EVACU:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-09-04 2026-09-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 4, 2026

 

EQV Ventures Acquisition Corp. II

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42729   98-1810179
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

1090 Center Drive

Park City, Utah

  84098
(Address of principal executive offices)   (Zip Code)

 

(405) 870-3781

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and one-third of one redeemable warrant   EVAC U   New York Stock Exchange
Class A ordinary shares, par value $0.0001 per share   EVAC   New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   EVAC WS   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Director Resignation

 

On September 4, 2026, Bryan Summers resigned from the Board of Directors (the “Board”) of EQV Ventures Acquisition Corp. II (the “Company”), including the Nominating and Corporate Governance Committee (the “Nominating Committee”) and the Compensation Committee (the “Compensation Committee”) thereof, effective immediately (the “Director Resignation”). The Director Resignation was not related to a disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. The Board thanks Mr. Summers for his service on the Board and valuable contributions to the Company. 

 

Board Committee Composition

 

In connection with the Director Resignation, on September 11, 2026, the Board reconstituted its committee memberships as follows (the “Committee Reconstitution”):

 

(i)Derek Rush and Marc Peperzak were appointed as members of the Nominating Committee, with Jerome C. Silvey, Jr., an existing member of the Nominating Committee, being appointed as the Chair of the Nominating Committee; and

 

(ii)Mr. Rush and Mr. Silvey, Jr. were appointed to the Compensation Committee, with Mr. Rush being appointed as the Chair of the Compensation Committee.

 

Following the Committee Reconstitution, the Board’s committee composition is now as follows:

 

Audit Committee: Andrew Blakeman (Chair), Marc Peperzak and Derek Rush.
   
Compensation Committee: Derek Rush (Chair) and Jerome C. Silvey, Jr.
   
Nominating and Corporate Governance Committee: Jerome C. Silvey, Jr. (Chair), Andrew Blakeman, Marc Peperzak and Derek Rush.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

104   Cover Page Interactive Data File (embedded within the inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 11, 2026 EQV VENTURES ACQUISITION CORP. II
   
  By: /s/ Tyson Taylor
  Name:  Tyson Taylor
  Title: President and Chief Financial Officer

 

 

2

 

 

Filing Exhibits & Attachments

4 documents

Keep reading